Dexamethasone as an Analgesic Adjunct for Postcesarean Delivery Pain: A Randomized Controlled Trial
Table 1
Subject characteristics.
Dexamethasone (n = 23)
Placebo (n = 24)
Age (year)
32.2 (4.7)
30.63 (5.71)
Weight (kg)
90.9 (15.9)
84.9 (87.8)
BMI (kg/m2)
33.8 (5.9)
32.3 (5.1)
Race/ethnicity
Caucasian
17 (73.9%)
14 (58.3%)
Black/African American
6 (26.1%)
5 (20.8%)
Asian/Indian
0 (0.0%)
3 (12.5%)
Hispanic
0 (0.0%)
2 (8.3%)
ASA status
2
22 (95.6%)
23 (95.8%)
3
1 (4.4%)
1 (4.2%)
Gravidity
3 (2, 5)
2 (2, 4)
Parity
1 (1, 2)
1 (1, 1)
History of previous cesarean
17 (73.8%)
19 (79.2%)
History of IONV
4/18 (22.2%)
9/18 (50%)
History of PONV
5/18 (27.8%)
3/19 (15.8%)
History of smoking
Never smoked
15 (65.2%)
15 (62.5%)
Smoked prior to pregnancy
5 (21.2%)
6 (25.0%)
Current smoker
3 (13.0%)
3 (12.5%)
Uterus exteriorized
21 (91%)
24 (100%)
Abdominal irrigation after uterine closure
23 (100%)
23 (96%)
Duration of surgery (min)
70.4 (20.4)
64.0 (22.8)
Intraoperative fluids administered (mL)
2313 (536)
2297 (545)
Dose of phenylephrine administered (mg)
2.5 (1.7, 3.2)
2.3 (1.6, 3.2)
Estimated blood loss (mL)
826 (120)
717 (140)
Mean (SD) or n (%); median, (Q1, Q3); IONV, intraoperative nausea and vomiting; PONV, postoperative nausea and vomiting. Missing data and presented as observed count/total count per group.
